From The Tribune
Center Owned by The Tribune TrustIllumina selected to help bring precision medicine into everyday healthcare in Singapore
RSS excerpt
Singapore, November 5: Illumina, Inc. (Nasdaq: ILMN) announced it has been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine (NPM) programme. Expected to include approximately one in 10 Singapore…